Cartalax vs Epithalon — Peptide Comparison

Cartalax vs Epithalon — Peptide Comparison Cartalax vs Epithalon — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Cartalax 2–5 mg Epithalon 5–10 mg Frequency Once daily Administration Oral (capsule) Subcutaneous injection Cycle Length 12+ weeks 4-6 weeks Onset Speed Gradual (3-4 weeks) Evidence Level Moderate human trials (Phase 1-2) Limited human trials Efficacy Anti-Aging Healing & Recovery Hormone Support Telomere Protection Sleep Quality Cellular Longevity Technical Data Molecular Formula C12H19N3O8 Molecular Weight 333.3 g/mol Half-Life Short plasma half-life typical of tripeptides (minutes to hours); biological effects persist for weeks to months through epigenetic gene regulation; metabolized to constituent amino acids Bioavailability Orally bioavailable via intestinal peptide transporters (PepT1/PepT2, LAT1); 10-fold more potent than crude cartilage polypeptide complex at chondrogenic activation (200 vs 2000 ng/mL effective concentration) CAS Number Not yet registered (research compound) C14H22N4O9 390.35 g/mol 2-4 hours (estimated) High when injected subcutaneously 307297-39-8 Protocols standard 200 mcg 10-day cycles, repeated periodically Cartalax has only lab and cell-culture research, so there is no trial-set human dose. In practice it is commonly given as 200 mcg daily in short 10-day cycles, matching how other Khavinson short peptides are used [3][4]. 5-10 mg 10-20 day course, repeated 1-3 times per year Subcutaneous injection is the most common route used in practice, mirroring the dose used in the Russian intramuscular clinical literature [6]. Typically run as a short 10-20 day course a few times per year [3]. Intramuscular dosing of 5-10 mg/day for 10-20 days is the form used in Khavinson's original Russian clinical work in older adults [6]. Applications Cartilage regeneration and protection in age-related osteoarthritis Cartalax is particularly well-suited for individuals focused on cartilage regeneration and protection in age-related osteoarthritis. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Connective tissue repair and maintenance in aging individuals Cartalax is particularly well-suited for individuals focused on connective tissue repair and maintenance in aging individuals. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Geroprotective therapy targeting the SIRT-6/senescence axis in musculoskeletal tissue Cartalax is particularly well-suited for individuals focused on geroprotective therapy targeting the sirt-6/senescence axis in musculoskeletal tissue. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Complementing conventional osteoarthritis treatments with bioregulatory peptide therapy Cartalax is particularly well-suited for individuals focused on complementing conventional osteoarthritis treatments with bioregulatory peptide therapy. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Longevity Enthusiasts If you're serious about healthy aging and want to support your cells at the deepest level, Epithalon targets one of the fundamental mechanisms of cellular aging—telomere shortening. It's like giving your cells' protective caps a little extra reinforcement. Sleep Quality Seekers Epithalon helps regulate melatonin production by supporting your pineal gland. Many users report better sleep quality and more consistent sleep-wake cycles, especially those who've noticed their sleep getting worse with age. Those Concerned About Oxidative Stress Beyond its telomere effects, Epithalon acts as an antioxidant. If you're exposed to environmental stressors, have a demanding lifestyle, or simply want extra cellular protection, this peptide offers multiple mechanisms of support. Immune System Support (Age-Related) As we age, our immune system naturally weakens—a process called immunosenescence. Research suggests Epithalon may help maintain immune function by supporting the thymus and immune cell health, potentially keeping your defenses stronger as you age. Safety Profile Common Mild injection site reaction Mild GI discomfort Mild fatigue Transient joint stiffness Uncommon Temporary increase in joint discomfort Serious No documented serious adverse effects Injection site redness Mild headache Temporary fatigue Vivid dreams Sleep pattern changes Allergic reaction Research Status FDA Status Research compound Safety Overview Cartalax (polypeptide complex from bovine cartilage) has not undergone formal FDA approval or rigorous clinical safety trials. The safety profile is based on traditional use in Russia and Eastern Europe as a cartilage extract supplement, with limited published safety data. As a complex mixture of polypeptides, collagens, and proteoglycans, the actual active components and their pharmacology are undefined, making toxicity prediction impossible. Potential allergic reactions to bovine proteins exist, and contamination risks from source animal tissues cannot be ruled out without pharmaceutical manufacturing standards. Contraindications xKnown hypersensitivity to peptide bioregulators or constituent amino acids (alanine, glutamic acid, aspartic acid) xPregnancy and breastfeeding — insufficient reproductive safety data xActive joint infection — treat infection before initiating peptide bioregulator therapy xMalignant bone or cartilage tumors — proliferative effects of peptide bioregulators may be contraindicated Epithalon has shown a favorable safety profile across decades of research, primarily conducted in Russia. Studies spanning up to 15 years of follow-up have reported no severe adverse events in older adults using Epithalon or its natural precursor Epithalamin. The peptide appears well-tolerated with minimal side effects, mostly limited to mild injection site reactions. However, large-scale clinical trials outside of Russia are still needed. xPregnancy or planning to become pregnant xCurrently breastfeeding xActive cancer or history of cancer xKnown allergy to peptide components xChildren and adolescents Decision Guide Choose Cartalax if... Cartilage regeneration and protection in age-related osteoarthritis Connective tissue repair and maintenance in aging individuals Geroprotective therapy targeting the SIRT-6/senescence axis in musculoskeletal tissue Complementing conventional osteoarthritis treatments with bioregulatory peptide therapy Choose Epithalon if... Longevity and healthy aging Cellular rejuvenation Sleep quality improvement Antioxidant support